May 21, 2015
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received the CE Mark for new molecular assays for the detection of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2), to be run on its molecular platform, illumigene®. The HSV 1&2 assays are additions to the portfolio of molecular tests available [...]
MBio Diagnostics, Inc. Closes $6.3 Million in Series B Funding
May 21, 2015
Boulder, CO -– MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced today the closing of $6.3 million in Series B financing led by new and existing private investors. The funding supports the refinement of the platform and improvements in manufacturing as the company executes a [...]
InDevR Launches Enhanced Flu Vaccine Potency Assay for All Stages of Bioprocessing
May 21, 2015
BOULDER, CO -- InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced the launch of the VaxArray™ Influenza potency assay, a new and re-branded version of the company's Influenza Titer on Chip® or Flu-ToC™ product. The VaxArray Influenza potency assay is a multiplexed immunoassay for hemagglutinin (HA) quantification that [...]
May 21, 2015
BILLERICA, Mass. -- Bruker Corporation (NASDAQ: BRKR) today announced that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO) of Bruker since July 2012, submitted his resignation, effective June 12, 2015, in order to pursue other interests. Mr. Wagner has informed the Company that he has [...]
BLUEBEE RAISES €1.75 MILLION INVESTEMENT
May 20, 2015
Bluebee announced toady it has raised 1.75 million EUR (1.90 million USD) from Belgian investment firm Buysse & Partners and existing shareholder Delft University of Technology to bring its cloud-based, accelerated genomics solution to clinicians and labs. Bluebee’s technology, based on hybrid-core computing (FPGA) allows clinicians to shorten the time-to-diagnosis substantially. “Our technology solves the [...]
Dassault Systèmes Announces Commercial Availability of Its First Simulated Human Heart
May 20, 2015
VÉLIZY-VILLACOUBLAY, France and BERLIN — — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced during its SIMULIA Community Conference that the first heart model from its “Living Heart Project” will be commercially available on May 29, [...]
908 Devices’ High-Pressure Mass Spectrometry (HPMS) To Power Next-Generation Chemical Detector Tools
May 20, 2015
908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, today announced that its patented High-Pressure Mass SpectrometryTM (HPMS) has been selected to move forward in the U.S. Army’s Next Generation Chemical Detector (NGCD) program. The contract supports the Army’s Chemical Biological Radiological Nuclear (CBRN) defense programs. Teaming for the NGCD program with Smiths [...]
Smiths Detection announces U.S. Army Award for Next Generation Chemical Detection Air Monitor
May 20, 2015
Edgewood, Md. -- Smiths Detection Inc.today announced it has been selected to move forward in a U.S. Army program for Next Generation Chemical Detection (NGCD) Platform/Site Air Monitor Variant technology. The contract supports the Army’s Chemical Biological Radiological Nuclear defense programs. Based on initial concept demonstrations, Smiths Detection Inc.(SDI) and subcontractor 908 Devices will jointly [...]
Dassault Systèmes Co-Leads the French Government Project “Industry of the Future”
May 20, 2015
VELIZY-VILLACOUBLAY, France -- Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced that it is co-leading the second phase of the French government’s strategic push for industrial modernization in France. The “Industry of the Future” initiative, announced [...]
Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers
May 20, 2015
SAN DIEGO -- Cypher Genomics, Inc., a leading genome informatics company, today announced a collaboration with Celgene Corporation to apply Cypher's CoralTM technology to discover novel genomic biomarkers that associate with patient response to innovative medicines. The information generated from the collaboration is intended to help accelerate patient access to the right medicine at the [...]

